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Abstract GTPases regulate a myriad of cellular functions
including signal transduction, cytoskeletal organization and
membrane trafficking. Rab GTPases act to coordinate the
membrane dynamics of cells by organizing and regulating the
activity of effector proteins important in vesicle trafficking.
Rab37 is a novel Rab GTPase specifically expressed in the MC-9
mast cell line and bone marrow mast cells. Rab37 is 74%
identical to Rab26 and 47% identical to Rab8, a GTPase
important in Golgi to plasma membrane vesicle trafficking in
mammalian cells. When green fluorescent protein tagged Rab37
is expressed in bone marrow mast cells, the secretory granules
are labeled. These data suggest that Rab37 may play an
important role in mast cell degranulation making this protein a
potentially important target for therapeutic intervention in the
treatment of allergy.
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1. Introduction
Eukaryotic cells rely on a series of membranous organelles
to compartmentalize biochemical reactions and to communi-
cate with the extracellular environment. Transport between
organelles occurs via the formation of a vesicle laden with
cargo, transport of the vesicle to a target membrane and fu-
sion of the vesicle and target membranes. In the ¢nal step of
the secretory pathway, exocytosis, secretory vesicles often de-
rived from the trans-Golgi network fuse with the plasma
membrane. Molecules such as receptors or extracellular ma-
trix components are deposited on the cell surface by constitu-
tive exocytosis. In contrast, release of neurotransmitters, se-
cretion of hormones, or secretion of in£ammatory mediators
from mast cells, occurs in a highly regulated fashion. The
action potential, releasing factors or hormones, or crosslink-
ing of the IgE receptor triggers these secretory events respec-
tively. The close coupling of secretion to a signaling event
requires regulatory proteins in addition to the basic compo-
nents that mediate vesicle tra⁄cking.
Many of the proteins important for vesicle tra⁄cking have
been characterized and their functions are becoming well de-
¢ned [1]. The Rab proteins comprise an important family of
low molecular weight GTPases critical for regulating vesicle
tra⁄cking [2]. Over 35 Rabs have been identi¢ed from mam-
malian species and each localizes to a particular membrane
compartment. Rab proteins act upstream of the membrane
fusion machinery by regulating the localization and activity
of e¡ector proteins. Rab e¡ector proteins have been proposed
to serve many functions. For example, Rab6 interacts with a
protein that has a molecular motor-like ATPase domain and
may function to translocate vesicles to target sites [3] while
Rab5 interacts with the early endosomal antigen 1 which may
be important in tethering organelles prior to the membrane
fusion event [4]. De¢ning the spectrum and function of Rab
proteins and their e¡ectors is an important area of investiga-
tion in membrane tra⁄cking.
Mast cells and basophils are hematopoietic lineage derived
cells that mediate allergic in£ammation [5]. The in£ammatory
response is due, in part, to the exocytosis of a variety of
molecules contained within dense core granules including his-
tamine, serotonin, and various proteases. While the widely
conserved mechanisms of exocytosis are likely to be utilized
for mast cell secretion, few of the speci¢c molecules involved
have been clearly identi¢ed and their functions assigned. In an
attempt to better understand secretory processes in mast cells,
we identi¢ed a novel Rab protein that is speci¢cally expressed
in mast cells and is selectively localized to the secretory gran-
ules. This molecule may be a target, or may be useful in
de¢ning targets, for molecules of therapeutic value in modu-
lating mast cell secretion.
2. Materials and methods
2.1. Cloning of Rab37
Using yeast two-hybrid screening, a novel cDNA clone interacting
with human Rab5 was identi¢ed out of eight million independent
yeast transformants derived from a murine mast cell line (MC9) li-
brary. Nucleotide sequencing revealed that the clone encoded the
101 carboxy-terminal amino acids of a novel member of the Rab
family of proteins. Clones containing the 5P sequence of the cDNA
were isolated by PCR from the MC-9 cDNA library using nested
primers. The nucleotide sequence was veri¢ed by checking it against
clones from over four independent PCR reactions. Northern blotting
was performed on a blot using 2 Wg poly(A) RNA per lane. A PCR
product ampli¢ed from nucleotides 385 to 749 of the Rab37 coding
region was used as a probe. As a control probe, a glyceraldehyde-3-
phosphate dehydrogenase (G3PDH) cDNA fragment (Clontech) was
used.
2.2. Antibody production
Custom rabbit antisera and the corresponding a⁄nity puri¢ed anti-
bodies were generated against the following peptides (Zymed Labo-
ratories): TAGDGEAPERSPPFSPNYD(C) (amino-terminal peptide)
and (C)KYRAGRQPDEPSFQIRDY (carboxy-terminal peptide),
where the cysteines in parentheses were added for single site conjuga-
tions to keyhole limpet hemocyanin. Antibodies were used to immu-
0014-5793 / 00 / $20.00 ß 2000 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 0 ) 0 1 2 8 8 - 6
*Corresponding author. Fax: (1)-650-624 1179.
E-mail: emasuda@rigel.com
FEBS 23429 9-3-00
FEBS 23429 FEBS Letters 470 (2000) 61^64
noprecipitate detergent extracts from cells. The resulting precipitates
were then analyzed by Western blotting. The bands were visualized by
enhanced chemiluminescence (Amersham).
2.3. Green £uorescent protein (GFP)^Rab37 fusion protein expression
All GFP fusion constructs were based on the pRGL103 retroviral
expression vector, which contains BstXI cloning sites at the 3P-end of
the GFP encoding sequence. The coding region for Rab37 was am-
pli¢ed by PCR and directionally cloned in frame at the 3P-end of the
GFP sequence into pRGL103 using £anking BstXI sites within the
following primers: 5P-CTGCAGAACCACCACCATGGCTGGCA-
CACCAGGAGCTGCTACC-3P and 5P-CAATGCATCCAATTTAA-
TGGCAGCTTCTCCTAGTTGGTGTGGC-3P. Rab37(T43N) and
Rab37(Q89L) mutants were generated by standard PCR techniques
using the above primers and in combination with the following
primers: for T43N, sense 5P-CGTCGGCAAGAACTGTTTCCTG-
ATCC-3P and antisense 5P-GGATCAGGAAACAGTTCTTGCC-
GACG-3P ; for Q89L, sense 5P-TGCAGGACTCGAGCGCTTCCGC-
AGTGTGA-3P and antisense 5P-AAGCGCTCGAGTCCTGCAGT-
GTCCCAG-3P
Viral constructs, infection protocols and lysotracker granule label-
ing have been described previously [6].
3. Results
Rab5 was used as a yeast two-hybrid bait to screen 8U106
independent clones from an MC9 mast cell line. Nucleotide
sequencing of the interacting clones revealed that two of the
clones encode Rab5 and Rab2 while the third appeared to
encode a novel Rab protein. A full-length clone for the novel
protein was isolated and characterized (see Section 2). The
clone encodes a predicted protein of 224 amino acids with
all of the characteristics of a Rab GTPase (Fig. 1). The se-
quence motifs predicted to be critical for guanine nucleotide
binding are highly conserved when Rab37 is compared to
other low molecular weight GTPases. In addition, a character-
istic pair of cysteine residues is found at the carboxy-terminus
of the protein. These residues likely serve as sites for isopre-
nylation, a modi¢cation important in membrane association.
Deletion of either ¢ve or 10 residues from the carboxy-termi-
nal end of the protein results in a Rab37^GFP fusion protein
that is cytosolic not vesicle associated (data not shown). The
predicted sequence is most similar to Rab26, a GTPase of
unknown function that is broadly expressed in somatic tissues
[7]. Rab37 has a 32 amino acid amino-terminal extension
compared to Rab26. One of our peptide antibodies was raised
to a region corresponding to the amino-terminal extension.
This antibody recognizes a band of the expected molecular
weight con¢rming that this predicted sequence is indeed trans-
lated. Rab37 may actually be a larger protein than Rab26, or
alternatively the predicted reading frame of Rab26 may be
incomplete at the amino-terminus. As is characteristic of
Rab proteins, the carboxy-terminal 30 residues comprise the
most divergent domains of the molecule when compared to
related sequences.
C
Fig. 1. Rab37 is a novel GTPase. The predicted amino acid se-
quence of murine Rab37 (GenBank AF233582 accession number)
aligned to rat Rab26 (74% identical), murine Rab8 (47% identical)
and yeast sec4 (36% identical). Residues that are conserved in all
four sequences are indicated in black and boxed residues are con-
served between two or more sequences. Bars over the sequences in-
dicate GTP binding domains and the arrow at the carboxy-terminus
is a conserved cysteine residue likely important for isoprenylation.
The two gray shaded sequences in Rab37 correspond to the peptides
used to raise antibodies.
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To better understand the potential function of Rab37, we
investigated the tissue distribution of expression and subcel-
lular localization of the protein. RNA was prepared from ¢ve
tissues and the MC-9 mast cell line. These RNAs were probed
for the presence of Rab37 or G3PDH transcripts (Fig. 2).
While all tissues and cells examined contain transcripts encod-
ing G3PDH, transcripts for Rab37 were only detected in the
MC-9 cell line. Two Rab37 transcripts of 2.3 and 1.2 kb are
observed. Since we only observe one protein, the di¡erence in
mRNA size may be due to alternative RNA splicing in the
untranslated region or alternative poly(A) addition sites.
To further investigate the distribution of Rab37, we gener-
ated two peptide antibodies. One antibody was raised against
a 19 amino acid peptide from the amino-terminal region of
the protein and the second was raised against an 18 amino
acid peptide from the carboxy-terminal region of Rab37. To
con¢rm the speci¢city of the antibodies we performed West-
ern blots on 293T cells transfected with vector or with a
Rab37 expressing construct. The appropriate size band was
only detected in transfected cells (Fig. 3A). Immunoprecipita-
tion with the amino-terminal antibody followed by Western
blots with the carboxy-terminal antibody revealed a band of
34 kDa in bone marrow mast cells but not in any of the other
16 tissues tested (Fig. 3B). If we ¢rst immunoprecipitate with
the carboxy-terminal antibody then probe with the amino-ter-
minal antibody similar results are obtained con¢rming the
speci¢city of the antibodies and the identity of the band.
The most dramatic feature of the mast cell cytoplasm is the
presence of a number of large secretory granules. Further-
more, the sequence homology of Rab37 to Rabs 26 [7] and
8 [8], as well as the yeast sec4 GTPase [9], suggests a function
late in the secretory pathway, perhaps at the step of secretory
granule exocytosis. To begin to test this prediction, we gen-
erated a retroviral expression construct containing Rab37
fused to GFP. Expression of this construct in bone marrow
mast cells revealed intense labeling of the secretory granules
(Fig. 4). Expression of GFP alone results in a di¡use cyto-
plasmic labeling as expected for a soluble protein. Further-
more, expression of a GDP stabilized mutant (T43N) of
Rab37^GFP also results in di¡use cytoplasmic labeling, while
expression of a GTP stabilized mutant (Q89L) localizes to
granules (Fig. 4A). The identity of the GFP^Rab37 labeled
organelles was con¢rmed by co-localization with lysotracker,
a marker of acidic secretory granules [10] (Fig. 4B). In addi-
tion, the mast cells contain a very high density of secretory
granules that are labeled by the SNARE protein GFP^
VAMP2. These data suggest that Rab37 is localized to the
Fig. 2. Rab37 mRNA is speci¢cally expressed in the MC-9 mast cell
line. Six RNA samples were fractionated by gel electrophoresis,
transferred to nitrocellulose and probed for either Rab37 or
G3PDH transcripts. All lanes contain intact mRNA as indicated by
the G3PDH hybridization, however transcripts encoding Rab37 are
found speci¢cally in mast cells. Sizes in kilobases are indicated to
the right.
Fig. 3. Rab37 is present in bone marrow mast cells but not detected
in 16 other tissues. A: HA^Rab37 is detected in transfected but not
untransfected 293T cells. Extracts were immunoprecipitated with the
amino-terminal peptide antibody and probed with the carboxy-ter-
minal antibody. Untransfected 293T cells (293) only show reactivity
with IgG while 293 cells expressing HA^Rab37 (293/HA^rab37)
have an additional band at 36 kDa. The HA^Rab37 protein is
slightly larger than endogenous Rab37 from bone marrow mast cells
(BMMC). B: The antibody raised against the amino-terminal
Rab37 peptide was used to immunoprecipitate 17 di¡erent protein
samples. The immunoprecipitates were then probed for the presence
of Rab37 using the antibody raised against the carboxy-terminal
peptide. Only bone marrow mast cells (BMMC) express the protein
at a molecular weight of 34 kDa. The bands above 36 kDa, present
in all samples, arise from reactivity with the antibodies used for the
immunoprecipitations. If the order of the antibodies is reversed a
similar result is obtained. Molecular weights in kilodaltons are indi-
cated to the right.
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secretory granules of mast cells, however conformation of this
hypothesis awaits direct detection of the endogenous protein.
The antibodies we have produced to date have proven inad-
equate for immunohistochemical analysis.
4. Discussion
Rab37 is a low molecular weight GTPase speci¢cally ex-
pressed in bone marrow mast cells and mast cell lines.
When expressed in mast cells, GFP tagged Rab37 is localized
to secretory granules. These observations are most consistent
with the hypothesis that Rab37 plays a role in exocytosis of
mast cell dense core granules. Perhaps Rab37 is important in
recruiting e¡ector proteins to the membrane of the mast cell
granule. Rab37 and its e¡ector proteins are likely to function
upstream of the actual membrane fusion event that releases
the granule contents. Rab37 may function in regulating vesicle
attachment to the cytoskeleton, granule translocation to the
plasma membrane, or organizing the vesicle and target mem-
brane associated fusion machinery.
The speci¢city of Rab37 expression suggests this GTPase
may interact with mast cell speci¢c e¡ector proteins. The spe-
ci¢city of expression further suggests that Rab37, or associ-
ated proteins, may be useful target proteins for the develop-
ment of therapeutic agents that will block mast cell
degranulation. These agents could be useful in the treatment
of allergy.
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Fig. 4. Rab37 is localized to bone marrow mast cell granules.
A: GFP expression in bone marrow mast cells results in cytoplas-
mic labeling. GFP^Rab37 expression in bone marrow mast cells re-
sults in secretory granule labeling. The GFP^Rab37 T43N (GDP
stabilized) mutant expressed in bone marrow mast cells results in cy-
toplasmic labeling. The GFP^Rab37 Q89L (GTP stabilized) mutant
expressed in bone marrow mast cells results in secretory granule la-
beling. B: GFP^Rab37 and lysotracker label the same organelles
con¢rming the identity of secretory granules. GFP^VAMP2 also la-
bels granules that are packed at high density in the bone marrow
mast cells. Size bar = 3 Wm.
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